As optineurin acts as a receptor during mitophagy (23), a pathway in which its dysfunction is known to cause Parkinson’s (224), it is possible that hereditary or somatic mutations in genes encoding optineurin or TBK1 may lead to a Parkinsonian progression through mitophagic perturbation. Here, OPTN is linked to Parkinson disease.